Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
59 /100
HIGH RISK
Score updated Oct 13, 2026

NMTC — NeuroOne Medical Technologies Corporation Dilution Risk Tracker

Track NMTC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NMTC — Get alerts when the score changes →

As of October 13, 2026, NeuroOne Medical Technologies Corporation (NMTC) has a DilutionWatch DilutionScore of 59/100, rated HIGH dilution risk. NeuroOne Medical Technologies Corporation has a market capitalization of $9.79M, 9.11M shares outstanding, 34 institutional holders tracked. Stored dilution-related fields include 144.0K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
85
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 43%
🔁 Convertible Conversion model 60%
• Major convertible overhang: 22520% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise model 35%
• Low cash runway: 4 months remaining
🔄 Reverse Split model est. 15%
• Only 4 months cash — financial pressure
🔔 Track NMTC — Get forecast alerts →

Market Data

Market Cap$9.79M
Shares Outstanding9.11M
Float7.82M
Cash$3.04M
Debt$121.9K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore59/100DilutionWatch score record
Shares Outstanding9.11MVerified float table or market cache
Public Float7.82MVerified float table or market cache
Market Cap$9.79MMarket data cache
Cash Runway3.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants144.0KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 4, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 6.3% shares (2026Q1 vs prior)
34 institutional holders · 13.36M shares
#1 Bleichroeder LP 4.00M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 2.79M shares
#3 BARD ASSOCIATES INC 1.84M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest178.7K
Days to Cover1.2
% of Float2.3%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-17
xbrl XBRL CONVERTIBLE 2022-12-22
4 INSIDER TRANSACTION 2026-04-07
4 INSIDER TRANSACTION 2026-04-07
4 INSIDER TRANSACTION 2026-04-07
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual NMTC Dilution Snapshot

NeuroOne Medical Technologies Corporation (NMTC) has a DilutionScore of 59/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

NMTC's DilutionScore is currently 59/100 (High risk), with 3 score changes tracked over 89 days. The score deteriorated from 63/100 (High risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202659/100HIGH16 days
Aug 22 – Sep 27, 202663/100HIGH37 days
Aug 14 – Aug 21, 202654/100HIGH7 days
Jul 16 – Aug 13, 202668/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

NMTC shares outstanding have decreased 82.9% from 50.53M (Mar 2026) to 8.62M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 15, 20268.62M7.82M▲ 2.36%
Apr 26, 20268.45M7.64M▼ 1.35%
Apr 24, 20268.45M7.75M▼ 0.02%
Apr 16, 20268.45M7.75M▼ 83.33%
Apr 07, 202650.69M46.49M▲ 0.03%
Mar 05, 202650.53M46.48M▼ 2.08%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track NMTC Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment NMTC files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking NMTC — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NMTC
NMTC FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.